Immunotherapy of american cutaneous leishmaniasis in Venezuela during the period 1990-99.

Convit, J; Ulrich, M; Zerpa, O; Borges, R; Aranzazu, N; Valera, M; Villarroel, H; Zapata, Z; Tomedes, I

Convit, J; Ulrich, M; Zerpa, O; Borges, R; Aranzazu, N; Valera, M; Villarroel, H; Zapata, Z; Tomedes, I.

Affiliation

Convit J; Instituto de Biomedicina, Universidad Central de Venezuela/Ministerio de Salud y Desarrollo Social, Apartado 4043, Caracas, 1010A, Venezuela. jconvi@telcel.net.ve

Trans R Soc Trop Med Hyg ; 97(4): 469-72, 2003.

Article in En | MEDLINE | ID: mdl-15259484

Subject(s)

BCG Vaccine/therapeutic use; Leishmaniasis, Cutaneous/drug therapy; Protozoan Vaccines/therapeutic use; Animals; Humans; Leishmania mexicana/immunology; Leishmaniasis, Cutaneous/immunology; Skin Tests; Treatment Failure; Treatment Outcome; Vaccines, Combined/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: BCG Vaccine / Protozoan Vaccines / Leishmaniasis, Cutaneous Limits: Animals / Humans Country/Region as subject: America do sul / Venezuela Language: En Journal: Trans R Soc Trop Med Hyg Year: 2003 Document type: Article Affiliation country: Venezuela Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links